Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week
Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by
deficient α-galactosidase A activity that leads to an accumulation of globotriasylceramide …
deficient α-galactosidase A activity that leads to an accumulation of globotriasylceramide …
The rapidly evolving view of lysosomal storage diseases
Lysosomal storage diseases are a group of metabolic disorders caused by deficiencies of
several components of lysosomal function. Most commonly affected are lysosomal …
several components of lysosomal function. Most commonly affected are lysosomal …
Fabry disease–a multisystemic disease with gastrointestinal manifestations
M Lenders, E Brand - Gut Microbes, 2022 - Taylor & Francis
Nonspecific gastrointestinal (GI) symptoms, such as postprandial cramping pain, diarrhea,
nausea and vomiting are typical symptoms for irritable bowel syndrome or inflammatory …
nausea and vomiting are typical symptoms for irritable bowel syndrome or inflammatory …
Gaucher disease–more than just a rare lipid storage disease
J Roh, S Subramanian, NJ Weinreb… - Journal of Molecular …, 2022 - Springer
Gaucher disease (GD), one of the most common lysosomal storage diseases, is caused by
mutations in the gene, GBA1, that leads to defective glucocerebrosidase activity resulting in …
mutations in the gene, GBA1, that leads to defective glucocerebrosidase activity resulting in …
Human in vitro models for Fabry disease: new paths for unravelling disease mechanisms and therapies
C Borisch, T Thum, C Bär, J Hoepfner - Journal of Translational Medicine, 2024 - Springer
Fabry disease is a multi-organ disease, caused by mutations in the GLA gene and leading to
a progressive accumulation of glycosphingolipids due to enzymatic absence or malfunction …
a progressive accumulation of glycosphingolipids due to enzymatic absence or malfunction …
Secondary mitochondrial dysfunction as a cause of neurodegenerative dysfunction in lysosomal storage diseases and an overview of potential therapies
KM Stepien, N Cufflin, A Donald, S Jones… - International Journal of …, 2022 - mdpi.com
Mitochondrial dysfunction has been recognised a major contributory factor to the
pathophysiology of a number of lysosomal storage disorders (LSDs). The cause of …
pathophysiology of a number of lysosomal storage disorders (LSDs). The cause of …
CRISPR/Cas9 editing for gaucher disease modelling
Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder caused by
mutations in the acid β-glucosidase gene (GBA1). Besides causing GD, GBA1 mutations …
mutations in the acid β-glucosidase gene (GBA1). Besides causing GD, GBA1 mutations …
Pentosan polysulfate to control hepcidin expression in vitro and in vivo
M Asperti, A Denardo, M Gryzik, A Castagna… - Biochemical …, 2020 - Elsevier
Hepcidin peptide is crucial in the regulation of systemic iron availability controlling its uptake
from the diet and its release from the body storage tissues. Hepcidin dysregulation causes …
from the diet and its release from the body storage tissues. Hepcidin dysregulation causes …
[HTML][HTML] The heart in Fabry disease: mechanisms beyond storage and forthcoming therapies
M Pieroni, M Ciabatti, F Graziani… - Reviews in …, 2022 - imrpress.com
In patients with Fabry disease (FD), cardiovascular involvement is the main cause of death
and reduction of quality of life. Left ventricular hypertrophy mimicking hypertrophic …
and reduction of quality of life. Left ventricular hypertrophy mimicking hypertrophic …
Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology
Gaucher disease (GD) is caused by biallelic pathogenic variants in the acid β-glucosidase
gene (GBA1), leading to a deficiency in the β-glucocerebrosidase (GCase) enzyme activity …
gene (GBA1), leading to a deficiency in the β-glucocerebrosidase (GCase) enzyme activity …